Novo Holdings A/S → Cyteir Therapeutics, Inc.

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

35 filings by this filer

34 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by Novo Holdings A/S

Filed	Form	Issuer	Stake	Shares
2026-01-23	SCHEDULE	IO Biotech, Inc. IOBTQ	3.30%	2,469,135	view →
2025-01-16	SCHEDULE	Galecto, Inc. DMRA	7.60%	99,913	view →
2024-03-18	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2024-01-02	SC	Rallybio Corp RLYB	—	—	view →
2023-08-11	SC	IO Biotech, Inc. IOBTQ	—	—	view →
2023-06-06	SC	LAVA Therapeutics NV	—	—	view →
2023-02-24	SC	LAVA Therapeutics NV	—	—	view →
2023-02-21	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2022-10-24	SC	Milestone Pharmaceuticals Inc. MIST	—	—	view →
2022-10-03	SC	LAVA Therapeutics NV	—	—	view →
2022-09-26	SC	Milestone Pharmaceuticals Inc. MIST	—	—	view →
2022-09-16	SC	Edgewise Therapeutics, Inc. EWTX	—	—	view →
2022-08-18	SC	Mirum Pharmaceuticals, Inc. MIRM	—	—	view →
2022-07-15	SC	Bolt Biotherapeutics, Inc. BOLT	—	—	view →
2022-02-22	SC	Morphic Holding, Inc.	—	—	view →
2022-01-27	SC	Reneo Pharmaceuticals, Inc. OKUR	—	—	view →
2021-11-22	SC	SPRUCE BIOSCIENCES, INC. SPRB	—	—	view →
2021-11-22	SC	Nkarta, Inc. NKTX	—	—	view →
2021-11-22	SC	Bolt Biotherapeutics, Inc. BOLT	—	—	view →
2021-08-12	SC	Morphic Holding, Inc.	—	—	view →

Showing 20 of 34

Novo Holdings A/S → Cyteir Therapeutics, Inc.

Item 4 — Purpose of Transaction

Cross-References

Other Filings by Novo Holdings A/S

Want this depth on every filing the moment it hits SEC EDGAR?